Rationale We have recently demonstrated that the reduction of histone Cell lysis & Western blotting: Whole cell extraction was performed using modified RIPA buffer. Proteins were size-fractionated and transferred on nitrocellulose membranes and phospho Akt and Akt band intensities were detected by chemiluminescence.
Here we show that CEM-101, a novel macrolide/fluoroketolide, which has potent activities against many bacteria causing pneumonia (starting Phase 2), reverses oxidative stress-dependent CS insensitivity via inhibition of PI3K signaling. Methods: CS sensitivity was determined by calculation of IC 50 value of dexamethasone on TNFα-induced IL-8 production in U937 monocytic cell line. HDAC activity and phosphorylation level of Akt as a marker of PI3K activation were measured by fluorescence based RNA extraction & Real time PCR: RNA was extracted using the RNeasy Mini kit (Qiagen) and reversed transcribed using the High Capacity cDNA reverse transcription kit (Applied Biosystems). HDAC2 and GNB2L1 mRNA expression levels were quantitated by real-time PCR using the TaqMan ® Gene Expression Master Mix (Applied Biosystems) on a Rotor-Gene 6000 (Corbett Research). μM) restored HDAC activity and HDAC2 expression reduced under oxidative stress and also inhibited Akt phosphorylation, which effects were more potent than those of any macrolides currently used clinically. Conclusion: CEM-101 restores CS sensitivity in oxidative stress-dependent CS insensitive model via enhancement of HDAC activity/expression due to PI3K signaling inhibition. This novel fluoroketolide, CEM-101, has potential for a novel treatment of COPD or severe asthma, which are steroid insensitive.
• Oxidative stress impaired corticosteroid sensitivity in parallel with reduction of total HDAC activity/HDAC2 mRNA expression and elevation of Akt phosphorylation.
• CEM-101 (10 μM) significantly restored corticosteroid sensitivity in our oxidative stress model. On the other hand, other macrolides did not improve sensitivity even at 10 times higher concentration.
• CEM-101 (10 to 100 μM) reversed total HDAC activity and HDAC2 mRNA expression dose-dependently under oxidative stress Other macrolides restored them • CEM-101 concentration-dependently inhibited H 2 O 2 -induced Akt phosphorylation up to 80 %. Although other macrolides inhibited it, the efficacies were less than that of CEM-101.
• This study shows that a novel macrolide, CEM-101 restored corticosteroid sensitivity through PI3K pathway dependent-enhancement of HDAC activity/expression under production were calculated using Prism. • Erythromycin has been shown to increase HDAC2 levels by activating the HDAC2 promoter [5] . 
